Just in, from our friend, Dr. Scott Perry

This amazing news just in from our friend Dr. Scott Perry : It has been an exciting journey as PI of Swallowtail, the open label extension study for STK-001, working alongside Stoke Therapeutics to develop disease-modifying therapy for Dravet! Looking forward to...